Research Article
A Combination of UTMD-Mediated HIF-1α shRNA Transfection and TAE in the Treatment of Hepatic Cancer
Figure 6
The relative expression of VEGF in four groups. A: Control group; B: UTMD group; C: TAE group; D: UTMD+TAE group. The comparison between two groups at the same time, p<0.05: comparison with control group; #p<0.05: comparison with UTMD group; Δp<0.05: comparison with TAE group (n=3).